Structure Therapeutics Inc. (GPCR) Insider Trading -- Recent Executive & Director Transactions

7 insiders reported 36 Form 4 transactions for Structure Therapeutics Inc. (GPCR) over the past 18 months (most recent 2026-04-23). Recent activity: Lang Matthew (COO & GC) Buy 184,614 shares, Lin Xichen (CHIEF SCIENTIFIC OFFICER) Buy 43,368 shares, Coll Crespo Blas (CHIEF MEDICAL OFFICER) Buy 75,897 shares, Stevens Raymond C (CHIEF EXECUTIVE OFFICER) Buy 260,217 shares, Hall Ashley (Chief Development Officer) Buy 47,706 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-04-23Lang MatthewCOO & GCBuy184,614$0
2026-03-23Lin XichenCHIEF SCIENTIFIC OFFICERBuy43,368$0
2026-03-23Coll Crespo BlasCHIEF MEDICAL OFFICERBuy75,897$0
2026-03-23Stevens Raymond CCHIEF EXECUTIVE OFFICERBuy260,217$0
2026-03-23Hall AshleyChief Development OfficerBuy47,706$0
2026-03-23Yoon JunCHIEF FINANCIAL OFFICERBuy104,085$0
2026-03-23Ma YingliCHIEF TECHNOLOGY OFFICERBuy32,526$0
2026-03-05Yoon JunCHIEF FINANCIAL OFFICERSell22,305$468,182
2026-03-05Stevens Raymond CCHIEF EXECUTIVE OFFICERSell53,454$1.1M
2026-03-05Hall AshleyChief Development OfficerSell4,836$101,508
2026-03-05Lin XichenCHIEF SCIENTIFIC OFFICERSell18,735$393,248
2026-03-05Ma YingliCHIEF TECHNOLOGY OFFICERSell11,313$237,460
2026-03-05Coll Crespo BlasCHIEF MEDICAL OFFICERSell11,826$248,228
2025-09-22Coll Crespo BlasCHIEF MEDICAL OFFICERSell8,106$62,740
2025-09-22Hall AshleyChief Development OfficerSell6,021$46,603
2025-08-20Ma YingliCHIEF TECHNOLOGY OFFICERSell4,470$30,575
2025-08-20Lin XichenCHIEF SCIENTIFIC OFFICERSell12,846$87,867
2025-07-03Stevens Raymond CCHIEF EXECUTIVE OFFICERBuy89,697$0
2025-07-03Yoon JunCHIEF FINANCIAL OFFICERSell5,940$47,045
2025-07-03Yoon JunCHIEF FINANCIAL OFFICERBuy39,606$0
2025-07-03Yoon JunCHIEF FINANCIAL OFFICERSell7,089$48,489
2025-07-03Coll Crespo BlasCHIEF MEDICAL OFFICERSell1,233$9,765
2025-07-03Coll Crespo BlasCHIEF MEDICAL OFFICERBuy7,992$0
2025-07-03Coll Crespo BlasCHIEF MEDICAL OFFICERSell1,434$9,809
2025-07-03Stevens Raymond CCHIEF EXECUTIVE OFFICERSell12,495$98,960

Source: SEC Form 4 filings · as of 2026-04-23